Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Mitchell Kapoor from H.C. Wainwright issued a price target of $75.00 for LEGN on 2025-03-12 10:13:54.The adjusted price target was set to $75.00.At the time of the announcement,
March 12, 2025 LEGN 5.46%
Surinder Thind from Jefferies issued a price target of $55.00 for WNS on 2025-01-21 14:15:45.The adjusted price target was set to $55.00.At the time of the announcement, WNS...
January 21, 2025 WNS -0.06%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| QNRX Quoin Pharmaceuticals, Lt | 0.29
38.23% | ||||||||||||||||||
| ADAP Adaptimmune Therapeutics | 0.31
22.00% | ||||||||||||||||||
| SLN Silence Therapeutics plc | 2.89
19.42% | ||||||||||||||||||
| DBVT DBV Technologies S.A. | 7.70
19.20% | ||||||||||||||||||
| XYF X Financial | 16.17
13.87% | ||||||||||||||||||
| AUTL Autolus Therapeutics plc | 1.57
11.35% | ||||||||||||||||||
| CMPS COMPASS Pathways plc | 3.09
10.75% | ||||||||||||||||||
| CNTB Connect Biopharma Holding | 0.63
10.21% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 0.00%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK 3.15%